The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120 low- and middle-income countries starting in 2027, under a new partnership announced today between Dr. Reddy’s Laboratories and Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI.| Clinton Health Access Initiative
Effective altruism is a project that aims to find the best ways to help others, and put them into practice. It’s partly a research field, which aims to identify the world’s most pressing problems and| www.effectivealtruism.org